International Immunology Advance Access originally published online on June 20, 2005
International Immunology 2005 17(7):909-919; doi:10.1093/intimm/dxh271
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation
1 Immunotherapy Center and 2 Department of Medicine, 3 Department of Surgery and 4 Department of Pediatrics, Medical College of Georgia, 1120, 15th Street, Augusta, GA 30912, USA
Correspondence to: A. L. Mellor; E-mail: amellor{at}mcg.edu
By ligating CD80/CD86 (B7) molecules, the synthetic immunomodulatory reagent CTLA4-Ig (soluble synthetic CTLA4 fusion protein) induces expression of the enzyme indoleamine 2,3-dioxygenase (IDO) in some dendritic cells (DCs), which acquire potent T cell regulatory functions as a consequence. Here we show that this response occurred exclusively in a population of splenic DCs co-expressing the marker CD19. B7 ligation induced activation of the transcription factor signal transducer and activator of transcription (STAT1) in sorted CD19+, but not CD19NEG, DCs. STAT1 activation occurred even when DCs lacked receptors for type II IFN (IFN
); however, STAT1 activation and IDO up-regulation were not observed when DCs lacked receptors for type I IFN (IFN
ß). Thus, IFN
, but not IFN
, signaling was essential for STAT1 activation and IDO up-regulation in CD19+ DCs following B7 ligation. Consistent with these findings, B7 ligation also induced sorted CD19+, but not CD19NEG, DCs to express IFN
. Moreover, recombinant IFN
induced CD19+, but not CD19NEG, DCs to mediate IDO-dependent T cell suppression, showing that IFN
signaling could substitute for upstream signals from B7. These data reveal that a minor population of splenic DCs expressing the CD19 marker is uniquely responsive to B7 ligation, and that IFN
-mediated STAT1 activation is an essential intermediary signaling pathway that promotes IDO induction in these DCs. Thus, CD19+ DCs may be a target for regulatory T cells expressing surface CTLA4, and may suppress T cell responses via induction of IDO.
Keywords: CTLA4-Ig, dendritic cells, interferon, STAT1, T cell suppression
* These authors contributed equally to this study.
Transmitting editor: E. Simpson
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Walter, C. Bonifer, and H. Tagoh Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus Blood, September 1, 2008; 112(5): 1673 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Orbach, J. Rachmilewitz, M. Parnas, J.-H. Huang, M. L. Tykocinski, and M. Dranitzki-Elhalel CTLA-4 {middle dot} FasL Induces Early Apoptosis of Activated T Cells by Interfering with Anti-Apoptotic Signals J. Immunol., December 1, 2007; 179(11): 7287 - 7294. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John and P. J. Nelson Dendritic Cells in the Kidney J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2628 - 2635. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Kin and V. M. Sanders CD86 Regulates IgG1 Production via a CD19-Dependent Mechanism J. Immunol., August 1, 2007; 179(3): 1516 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Watanabe, M. Fujimoto, N. Ishiura, Y. Kuwano, H. Nakashima, N. Yazawa, H. Okochi, S. Sato, T. F. Tedder, and K. Tamaki CD19 Expression in B Cells Is Important for Suppression of Contact Hypersensitivity Am. J. Pathol., August 1, 2007; 171(2): 560 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boasso, J.-P. Herbeuval, A. W. Hardy, S. A. Anderson, M. J. Dolan, D. Fuchs, and G. M. Shearer HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells Blood, April 15, 2007; 109(8): 3351 - 3359. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Forsythe, M. D. Inman, and J. Bienenstock Oral Treatment with Live Lactobacillus reuteri Inhibits the Allergic Airway Response in Mice Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 561 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-Y. Hou, A. J. Muller, M. D. Sharma, J. DuHadaway, T. Banerjee, M. Johnson, A. L. Mellor, G. C. Prendergast, and D. H. Munn Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses Cancer Res., January 15, 2007; 67(2): 792 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Mellor, B. Baban, P. R. Chandler, A. Manlapat, D. J. Kahler, and D. H. Munn Cutting Edge: CpG Oligonucleotides Induce Splenic CD19+ Dendritic Cells to Acquire Potent Indoleamine 2,3-Dioxygenase-Dependent T Cell Regulatory Functions via IFN Type 1 Signaling J. Immunol., November 1, 2005; 175(9): 5601 - 5605. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fallarino, C. Orabona, C. Vacca, R. Bianchi, S. Gizzi, C. Asselin-Paturel, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells Int. Immunol., November 1, 2005; 17(11): 1429 - 1438. [Abstract] [Full Text] [PDF] |
||||






